<i>In Vivo</i> Models and <i>In Vitro</i> Assays for the Assessment of Pertussis Toxin Activity
One of the main virulence factors produced by <i>Bordetella pertussis</i> is pertussis toxin (PTx) which, in its inactivated form, is the major component of all marketed acellular pertussis vaccines. PTx ADP ribosylates Gα<sub>i</sub> proteins, thereby affecting the inhibitio...
Main Author: | Marieke Esther Hoonakker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/13/8/565 |
Similar Items
-
Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
by: Kevin Markey, et al.
Published: (2019-07-01) -
Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
by: I. A. Alekseeva, et al.
Published: (2021-03-01) -
Pertussis Toxin: A Key Component in Pertussis Vaccines?
by: Kelsey A. Gregg, et al.
Published: (2019-09-01) -
Effects of pertussis toxin and <i>Bordetella pertussis</i> lipo-oligosaccharide on the specific toxicity and potency of whole-cell pertussis vaccines
by: I. A. Alekseeva, et al.
Published: (2023-10-01) -
Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity
by: Ewa Szwejser-Zawislak, et al.
Published: (2022-12-01)